DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2016" report to their offering.
The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies.
The majority of deals are multicomponent whereby the licensee retains either a right or option to license to commercialize the resultant product of the research collaboration. There are also numerous pure licensing deals whereby the products originator takes on a development/commercialization partner in order to maximize a technologies/products prospects.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all licensing deals announced since 2010 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010- 2016 available deals and contracts are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Key Topics Covered:
2 Trends in licensing deal making
3 Overview of licensing deal structure
4 Leading licensing deals
5 Top 50 most active licensing dealmakers
6 Licensing deal term financials
7 Licensing contract directory 2010 - 2016
For more information about this report visit http://www.researchandmarkets.com/research/gb4t24/global_licensing